...
首页> 外文期刊>Neuropharmacology >A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain
【24h】

A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain

机译:一种通过跨膜结构域作用的新型NMDA受体阳性变构调制剂

获取原文
获取原文并翻译 | 示例

摘要

Ionotropic glutamate receptors (iGluRs) mediate fast excitatory neurotransmission and are key nervous system drug targets. While diverse pharmacological tools have yielded insight into iGluR extracellular domain function, less is known about molecular mechanisms underlying the ion conduction gating process within the transmembrane domain (TMD). We have discovered a novel NMDAR positive allosteric modulator (PAM), GNE-9278, with a unique binding site on the extracellular surface of the TMD. Mutation of a single residue near the Lurcher motif on GluN1 M3 can convert GNE-9278 modulation from positive to negative, and replacing three AMPAR pre-M1 residues with corresponding NMDAR residues can confer GNE-9278 sensitivity to AMPARs. Modulation by GNE-9278 is state-dependent and significantly alters extracellular domain pharmacology. The unique properties and structural determinants of GNE-9278 reveal new modulatory potential of the iGluR TMD. (C) 2017 The Authors. Published by Elsevier Ltd.
机译:离子型谷氨酸受体(IGLURS)介导快速兴奋性神经递质,是关键神经系统药物靶标。 虽然不同的药理学工具已经产生了IGLUR细胞外结构域功能的洞察力,但是关于跨膜结构域(TMD)内的离子传导门控过程的分子机制较少。 我们已经发现了一种新型NMDAR阳性变构调制剂(PAM),GNE-9278,在TMD的细胞外表面上具有独特的粘合位点。 在GLUN1M3上的淋巴丝丝酰基附近的单个残留物的突变可以转化为负至阴性的GNE-9278调节,并用相应的NMDAR残基替换三个AMPAR预残留物可以赋予GNE-9278对AMPars的敏感性。 GNE-9278的调节是具有状态依赖性的,并且显着改变细胞外结构域药理学。 GNE-9278的独特性质和结构决定簇揭示了IGLUR TMD的新调制潜力。 (c)2017作者。 elsevier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号